Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer | iNFOnews | Thompson-Okanagan's News Source
Subscribe

Would you like to subscribe to our newsletter?

Current Conditions Cloudy  2.4°C

Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer

MONTREAL - Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX). Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company's shareholders last week.

News from © The Canadian Press, 2014
The Canadian Press

  • Popular kelowna News
View Site in: Desktop | Mobile